Oral alendronate in osteogenesis imperfecta.
We report a case of Osteogenesis Imperfecta (OI) in an eight-year-old boy who was admitted with complaints of recurrent long bone fractures. With oral alendronate treatment significant increment occurred in the bone mineral density and the number of fractures decreased. The usage of oral bisphosphonates is inexpensive and easy to administer in selected cases of OI. This case report supports the usage of oral alendronate treatment as an alternative treatment in OI.
Unal
Edip
E
Department of Pediatrics, and Division of Endocrinology, Dokuz Eylul University, Faculty of Medicine, Inciralti-Izmir, Turkey.
Abaci
Ayhan
A
Bober
Ece
E
Buyukgebiz
Atilla
A
D000284:Administration, Oral; D019386:Alendronate / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D008297:Male; D010013:Osteogenesis Imperfecta / Q000188:drug therapy*
D050071:Bone Density Conservation Agents; D019386:Alendronate